CAR-T cell therapy is a promising personalized approach in the treatment of acute or chronic leukemia. Find out more about the CAR therapy and its related chances and risks in this article.

In response to the changing process intensification, development, and production requirements, more labs are choosing an approach based on recyclable and extremely flexible single-use technologies

How biopharma companies are leveraging the speed and flexibility enabled by single use technologies and systems to navigate the maze to a vaccine against COVID-19.

One of the most renowned biopharmaceutical companies in India orders the complete product range of the start-up company Single Use Support based in Austria. The large order associated with this not only opens up the emerging Indian biopharma market, but also underlines the growing relevance of holistic process solutions.

Regardless of all potential pitfalls from the current pandemic Single Use Support has reached the next milestone in its thriving development: The large scale freeze/thaw platform has been commissioned on site in California/US virtually.

Thanks to a cooperation with BakerHicks, Single Use Support is now taking the qualification and validation strategies of mechatronic systems to the next level.

While technically simple to perform, the freeze-storage-thaw cycle comprises several mechanistic aspects that can compromise protein quality if not properly understood and addressed.

There are currently many options of primary packages on how to transport the drug substance from A to B. This paper explains the benefits and shortcomings of a few of those options.

Biopharma manufacturers are increasingly using single use tech for storage, shipping, and transfer of substances. Aabandoning cost-intensive and bulky platforms can save considerable amounts of money.

With bulk drug substances playing an increasingly important role in the industry, the need for a reliable freeze/thaw process as well as safe shipping and storage is more important than ever.

As geographic detachment of biopharmaceutical substance processing from final production becomes standard, freezing biopharmaceutical substances in single use containers offers several advantages.

Parts of a protein solution will show less activity based on the stress it's exposed to during freezing and thawing. It's important to optimize the freezing and thawing process to minimize activity loss.

Did you know that slow freezing kills up to 20% of the protein solutions in biopharmaceutical liquids? This case study shows how fast freezing with a plate freezer reduces the risk of cryoconcentration dramatically.

We close the gap between downstream and the fill & finish process in the biopharma industry. On the basis of single-use bags, we offer biopharma companies access to a new and almost 100% secure logistics process for liquids.

For any single use bag and any freezing infrastructure freeze your drug substance/product without worries! The right material at the right place – what we can learn from oysters. Tough protected & tamper evident! The tried and tested single-use bag gets its 100% secure and compact shell.

RoSS.pFTU is our “standard" freeze-thaw platform. It is suitable for different batch sizes and offers a fully scalable solution for medium-sized and large batch volumes. The platform is the perfect freeze & thaw single use option as it is compatible with single use bags from all established manufacturers as well as with different sizes and volumes.